5Doty TJ. Postmenopausal hormone replacement therapy after the Women's Health Initiative [J].JAAPA, 2005, 18 (1): 30-37.
6Koro CE, Lltalien GJ, Fedder Do. Major CHD risk factors predominate among Mrlcan - American women Who are eligible for lipid - lowering drug therapy under the new ATP Ⅲ guidelines [J]. Eur J Cardiovasc Prer Reliabil, 2004, 11 (5): 376-381.
7Rodriguez BL, Lau N, Burchfiel CM, et al. Glucose intolerance and 23 - year risk of coronary heart disease and total morlaliey : the Honolulu Heart Program [J] . Diabetes Care, 1999, 22 (8) : 1262 - 1265.
8Barrett - Conngr EL, Cohn BA, Wingard DL, et al. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in man? The Rrancho Bernardo study [J]. JAMA, 1991, 265: 627.
9Bush TL. The epidemiology of cardiovascular disease in Postmenspausal women [J] . Ann N Y Acad Sei, 1990, 592:263 -271.
10Kannel WB, Higglns M. Smoking and hypertension as Predictors of Cardiovascular risk in population studies [J] . J Hypertens, 1990, 8: 3.
